Chugai Pharmaceutical Co. Ltd. - Operating Expenses

Chugai Pharmaceutical Co. Ltd.'s Fiscal Year is From January To December - All Figures are in JPY, Billions.

The item "Operating-Expenses" stands at 278.88 Billion Japanese Yens for the trailing twelve months (TTM) period ending 06/30/2025.

Chugai Pharmaceutical Co. Ltd.'s second quarter result of 61.68 Billion JPY for the item "Operating Expenses" represents a decrease of -0.14 percent compared to it's first quarter result.

Also, Chugai Pharmaceutical Co. Ltd.'s second quarter result of 61.68 Billion JPY for the item "Operating Expenses" represents a decrease of -9.64 percent compared to it's second quarter result of last year.

Looking again at the trailing twelve months series (TTM), Chugai Pharmaceutical Co. Ltd.'s second quarter result of 278.88 Billion JPY for the item "Operating Expenses" represents a decrease of -2.30 percent compared to it's first quarter result.


Regarding the One-Year-Change of the series, the current value constitutes an increase of 2.96 percent compared to the value the year prior.
The 1 year change in percent is 2.96.
The 3 year change in percent is 18.95.
The 5 year change in percent is 35.75.
The 10 year change in percent is 63.45.

The Serie's long term average value is 197.75 Billion Japanese Yens. It's latest available value, on 06/30/2025, is 41.03 percent higher, compared to it's long term average value.
The Serie's change in percent from it's minimum value, on 09/30/2012, to it's latest available value, on 06/30/2025, is +105.31%.
The Serie's change in percent from it's maximum value, on 12/31/2024, to it's latest available value, on 06/30/2025, is -2.54%.